when did retatrutide come out Retatrutide - Wikipedia

This can lead to gastrointestinal symptoms, malnutrition, and unintended weight loss

But heres the part people often skip: These results come fromcontrolled clinical trials, not everyday public use

Summary The use of GLP-2 analogs is effective in the management of SBS-IF and may show promise in the treatment of other severe gastrointestinal disorders associated with loss of effective intestinal resorptive surface area.

In a 6-week randomized phase 1 trial, tirzepatide led to reduced caloric intake during a meal test at week 3 compared with placebo and liraglutide in people with overweight or obesity.

A large, randomized controlled trial comparing three time-restricted eating (TRE) windows found that time-restricted eating at any time of day is a promising strategy for losing weight but does not reduce visceral adipose tissue.